Catalyst Wire Dossier Catalyst Wire Dossier

Cetuximab

cetuximab · Eli Lilly
Drug timelines are a Plus or Pro feature.

477 regulatory and trial events tracked for Cetuximab, covering 2006-09-08 to 2026-07-30. Get the full timeline:

Most recent: Clinical Trial Results: Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Phase 2]

See pricing